T-Vec is also being considered for approval in the European Union.

The matter is likely to be considered for approval at the AGMs of both institutions later this year.

Vaccines must demonstrate they are at least 50% more effective than a placebo to be considered for approval.

Drugs generally aren't considered for approval by the FDA until completion of Phase III clinical trials, and acceptance of a New Drug Application.